Search Results 281-290 of 19255 for Pathophysiology

  1. Neurology - Clinical trials

    ... pathophysiology, neurodegeneration, and inflammation (“A,T,N,I”), and biological samples to advance the study of cognitively unimpaired older adults at six ...

  2. Hepatic encephalopathy - Symptoms and causes - Mayo Clinic

    Pathophysiology of hepatic encephalopathy: A framework for clinicians. Clinics in Liver Disease. 2023; doi:10.1016/j.cld.2024.01.002. Sahney A, et al ...

  3. Neurology - Clinical trials - Mayo Clinic

    ... pathophysiology, neurodegeneration, and inflammation (“A,T,N,I”), and biological samples to advance the study of cognitively unimpaired older adults at six ...

  4. Peptic ulcer - Symptoms and causes - Mayo Clinic

    In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 11th ed. Elsevier; 2021. https://www.clinicalkey ...

  5. Neurology - Clinical trials

    ... pathophysiology, neurodegeneration, and inflammation (“A,T,N,I”), and biological samples to advance the study of cognitively unimpaired older adults at six ...

  6. Neurology - Clinical trials

    ... pathophysiology, neurodegeneration, and inflammation (“A,T,N,I”), and biological samples to advance the study of cognitively unimpaired older adults at six ...

  7. Neurology - Clinical trials

    ... pathophysiology, neurodegeneration, and inflammation (“A,T,N,I”), and biological samples to advance the study of cognitively unimpaired older adults at six ...

  8. Michael A. Edwards, M.D. - Mayo Clinic Faculty Profiles

    Determine the epidemiology and pathophysiology for differences in obesity outcomes among racial and ethnic patient cohorts undergoing weight-loss procedures.

  9. Diabetic nephropathy (kidney disease) - Symptoms and causes - Mayo Clinic

    Kidney failure is a life-threatening condition. Treatment options for kidney failure are dialysis or a kidney transplant. How kidneys work.

  10. Petrice M. Cogswell, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    She seeks to use these biomarkers to better understand the pathophysiology of the condition, predict clinical outcomes and improve patient selection for shunt ...